ArticleTherapeutics and clinical risk management2019

Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis.

Emmanuel Kwateng Drokow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.